Adenovector-mediated expression of human thrombopoietin cDNA in immune- compromised mice: Insights into the pathophysiology of osteomyelofibrosis

Journal of Immunology

Volumn 160, Issue 2, 1998, Pages 691-699

  Frey, Beat M ^a,d   Rafii, Shahin ^b   Teterson, Michael ^c   Eaton, Dan ^c   Crystal, Ronald G ^b   Moore, Malcolm A S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c GENENTECH INC   (United States)

^d Stift Zurcher Blutspendedienst SRK   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; THROMBOPOIETIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; COMBINED IMMUNODEFICIENCY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MALE; MEGAKARYOPOIESIS; MOUSE; MYELOFIBROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRAIN DIFFERENCE; VIRUS EXPRESSION;

ADENOVIRUSES, HUMAN; ANIMALS; BLOOD PLATELETS; BONE MARROW CELLS; CLONE CELLS; DNA, COMPLEMENTARY; ERYTHROCYTES; GENE EXPRESSION REGULATION; GENETIC VECTORS; GRANULOCYTES; HUMANS; IMMUNOCOMPROMISED HOST; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, NUDE; MICE, SCID; MYELOFIBROSIS; PLATELET COUNT; THROMBOPOIETIN;

EID: 0031963996     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Kaushansky, K., S. Lok, R. D. Holly, V. C. Broudy, N. Lin, M. C. Bailey, J. W. Forstrom, M. M. Buddle, P. J. Oort, F. S. Hagen, G. J. Roth, T. Papayannopoulou, and D. C. Foster. 1994. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369:568.
2. Wendeling, F., E. Maraskovsky, N. Devili, C. Florindo, M. Teepe, D. Breton-Gorius, D. Cosman, and W. Vainchenker. 1994. c-Mpl ligand is a humoral regulator of megakaryopoiesis. Nature 369:571.
3. Lok, S., K. Kaushansky, R. D. Holly, J. L. Kuijper, C. E. Lofton-Day, P. J. Oort, F. J. Grant, M. D. Heipel, S. K. Burkhead, J. M. Kramer, L. A. Bell, C. A. Sprecher, H. Blumberg, R. Johnson, D. Prunkard, A. F. T. Ching, S. L. Mathewes, M. C. Balley, J. W. Forstrom, M. M. Buddle, S. G. Osborn, S. J. Evans, P. O. Sheppard, S. R. Presnell, P. J. O'Hara, F. S. Hagen, G. J. Roth, and D. C. Foster. 1994. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565.
4. Broudy, V. C., and K. Kaushansky. 1995. Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production. J. Leukocyte Biol. 57:719.
5. Foster, D. C., C. A. Sprecher, F. J. Grant, J. M. Kramer, J. L. Kuijper, R. D. Holly, T. E. Whitmore, M. D. Heipel, L. A. Bell, A. F. Ching, V. McGrane, C. Hart, P. J. O'Hara, and S. Lok. 1994. Human thrombopoietin: gene structure. cDNA sequence, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 91:13023.
6. Eaton, D. L., A. Gurney, B. Malloy, W. J. Kiang, P. E. Haas, M. R Xie, M. Nagel, and F. J. de Sauvage. 1994. Biological activity of human thrombopoietin (Tpo), the c-mpl ligand and the chromosomal localization of Tpo. Blood 84 (Suppl. 1):241a (Abstr.).
7. Carbonell, F., D. Hoelzer, E. Thiel, and R. Bartl. 1982. Ph1-positive CML associated with megakaryocytic hyperplasia and thrombocythemia and an abnormality of chromosome no. 3. Cancer Genet. Cytogenet. 6:153.
8. Bartley, T. D., J. Bogenberger, P. Hunt, Y. S. Li, H. S. Lu, F. Martin, M. S. Chang, B. Samal, J. L. Nichol, S. Swift, M. J. Johnson, R.-Y. Hsu, et al. 1994. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117.
9. Chang, M. S., J. McNinch, R. Basu, J. Shutter, R. Y. Hsu, C. Perkins, V. Mar, S. Suggs, A. Welcher, L. Li, H. Lu, T. Bartley, et al. 1995. Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene. J. Biol. Chem. 270:511.
10. Stoffel, R., A. Wiestner, and R. C. Skoda. 1996. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87:567.
11. Li, B., H. Pan, J. C. Winkelmann, and W. Dai. 1996. Thrombopoietin and its alternatively spliced form are expressed in human amygdala and hippocampus. Blood 87:5382.
12. Harker, L. A., P. Hunt, U. M. Marzec, A. B. Kelly, A. Tomer, S. R. Hanson, and R. B. Stead. 1996. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Blood 87:1833.
13. Ulich, T. R., J. del Castillo, S. Yin, S. Swift, D. Padilla, G. Senaldi, L. Benet, J. Shutter, J. Bogenberger, D. Sun, B. Samal, G. Shimamoto, R. Lee, R. Steinbrink, T. Boone, W. T. Sheridan, and P. Hunt. 1995. Megakaryocyte growth and developmental factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 86:971.
14. Hokom, M. M., D. Lacey, O. B. Kinstler, E. Choi, S. Kaufman, J. Faust, C. Rowan, E. Dwyer, J. L. Nichol, T. Grasel, J. Wilson, R. Steinbeck, et al. 1995. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood 86: 4486.
15. Yan, X. Q., D. Lacey, F. Fletcher, C. Hartley, P. McElroy, Y. Sun, M. Xia, S. Mu, C. Saris, D. Hill, R. G. Hawley, and I. K. McNiece. 1995. Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 86:4025.
16. Ohwada, A., S. Rafii, M. A. S. Moore, and R. G. Crystal. 1996. In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation- and chemotherapy-induced bone marrow suppression. Blood 88:778.
17. Yan, X. Q., D. Lacey, D. Hill, Y. Chen, F. Fletcher, R. G. Hawley, and I. K. McNiece. 1996. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood 88:402.
18. 1985 The BALB/c mouse: genetics and immunology. Curr. Top. Microbiol. Immunol. 122:1.
19. Festing, M. F. W. 1976. Inbred Strains in Biomedical Research. Oxford University Press, New York, p. 152.
20. Palacios, R., and J. Samaridis. 1991. Rearrangement patterns of T-cell receptor genes in the spleen of athymic (nu/nu) young mice. Immunogenetics 33:90.
21. Heberman, R. B. 1978. The Nude Mouse in Experimental and Clinical Research. Academic Press, New York, p. 79.
22. Schultz, L. D., and R. Badkey. 1987. Genetically determined murine models of immunodeficiency. Annu. Rev. Immunol. 5:367.
23. Lozzio, B. B., B. C. Giovanella, and B. L. Gallie. 1982. Nude mice with additional immunodeficiencies: genetically, anatomically and experimentally induced. In The Nude Mouse in Experimental and Clinical Research, 2nd Ed. J. Fogh and B. C. Giovanella, eds. Academic Press, New York, p. 79.
24. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527.
25. Dorshkind, K., S. B. Pollack, M. J. Bosma, and R. A. Phillips. 1985. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J. Immunol. 134:3798.
26. Leiter, E. H., M. Prochazka, and D. L. Coleman. 1987. The non-obese diabetic (NOD) mouse. Am. J. Pathol. 128:380.
27. Schultz, L. D., P. A. Schweitzer, S. W. Christianson, B. Gott, I. B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T. V. Rajan, D. L. Greiner, and E. H. Leiter. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154:180.
28. Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, L. Stratford-Perricaudet, M. Perricaudet, W. B. Guggino, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143.
29. Hersh, J., R. G. Crystal, and B. Bewig. 1995. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2:124.
30. Rosenfeld, M. A., W. Siegfried, K. Yoshimura, K. Yoneyama, M. Fukayama, L. E. Stier, P. K. Paakko, P. Gilardi, L. D. Stratford-Perricaudet, M. Perricaudet, S. Jallat, A. Pavirani, J.-P. Lecocq, and R G. Crystal. 1991. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252:431.
31. Emmons, R. V. B., D. M. Reid, R. L. Cohen, G. Meng, N. S. Young, C. E. Dunbar, and N. R. Shulman. 1996. Human thrombopoietin levels are high when thrombopoietin is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068.
32. Wilson, J. M. 1996. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334:1185.
33. Crystal, R. G., N. G. McElvaney, M. A. Rosenfeld, C. S. Chu, A. Mastrangeli, J. G. Hay, S. L. Brody, H. A. Jaffe, N. T. Eissa, and C. Danel. 1994. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8:42.
34. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407.
35. Dai, Y., E. M. Schwarz, D. Gu, W. W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401.
36. + CTLs in vivo. J. Immunol. 155:2564.
37. Feuerbach, F. J., and R. G. Crystal. 1996. Progress in human gene therapy. Kidney Int. 49:1791.
38. Castro-Malaspina, H., and S. C. Jhanwar. 1984. Properties of myelofibrosis-derived fibroblasts. Prog. Clin. Biol. Res. 154:307.
39. Castro-Malaspina, H., E. M. Rabellino, A. Yen, R. L. Nachman, and M. A. S. Moore. 1981. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 57:781.
40. Terui, T., Y. Niitsu, Y. Fujisaki, Y. Urushizaki, Y. Mogi, Y. Khogo, M. Ogura, and H. Saito. 1990. The production of transforming growth factor-β in acute megakaryocytic leukemia and its possible implications in myelofibrosis. Blood 75:1540.
41. Castro-Malaspina, H., and M. A. S. Moore. 1982. Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes. Nouv. Rev. Fr. Hematol. 24:221.
42. Castro-Malaspina, H. 1984. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. Prog. Clin. Biol. Res. 154: 427.
43. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151.
44. Zsengeller, Z. K., S. E. Wert, W. M. Hull, X. Hu, S. Yei, B. C. Trapnell, and J. A. Whitsett. 1995. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6:457.
45. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196.
46. Connelly, S., J. M. Gardner, R. M. Lyons, A. McClelland, and M. Kaleko. 1996. Sustained expression of therapeutic levels of human factor VIII in mice. Blood 87:4671.
47. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Long-term recombinant gene expression in adult immunocompetent animals following im injection of a replication-defective adenovirus. Nat. Med. 2:545.
48. Shivdasani, R. A., M. F. Rosenblatt, D. Zucker-Franklin, C. W. Jackson, P. Hunt, C. J. M. Saris, and S. H. Orkin. 1995. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695.
49. Basser, R., J. Rasko, K. Clarke, M. Green, J. Cebon, A. Grigg, M. Berndt, J. Zalcberg, J. Marty, D. Menchaca, D. Tomita, R. Fox, and G. Begley. 1996. Pegylated megakaryocyte growth and development factor (PEG-rHuMGDF) enhances the mobilization of peripheral blood progenitor cells (PBPC) by chemotherapy and filgrastim. Blood 88 (Suppl 1):641a.
50. Hoffman, R., E. Mazur, E. Bruno, and V. Floyd. 1981. Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies. N. Engl. J. Med. 305:533.
51. Mazur, E. M., P. de Alcon, K. South, and L. Miceli. 1984. Human serum megakaryocyte colony-stimulating activity increases in response to intensive cytotoxic chemotherapy. Exp. Hematol. 12:624.
52. Nichol, J. L., M. M. Hokom, A. Hornkohl, W. P. Sheridan, H. Ohashi, T. Kato, YS. Li, T. D. Bartley, E. Choi, J. Bogenberger, J. D. Skrine, A. Knudten, J. Chen, G. Trail, L. Sleeman, S. Cole, G. Grampp, and P. Hunt. 1995. Megakaryocyte growth and development factor. Analysis of in vitro effects on human megakaryopoiesis and endogenous levels during chemotherapy-induced thrombocytopenia. J. Clin. Invest. 95:2973.
53. Chang, M., Y. Suen, G. Meng, J. Buzby, S. Williams, V. Shen, A. Knoppel, G. Fernandez, and M. S. Cairo. 1995. Regulation of TPO mRNA expression and protein production: TPO gene regulation appears post transcriptional, and endogenous levels are inversely correlated to megakaryocyte mass and circulating platelet count. Blood 86(Suppl. 1):368a.
54. Ku, H., Y. Yonemura, K. Kaushansky, and M. Ogawa. 1996. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87:4544.
55. Ramsfjell, V., O. J. Borge, O. P. Veiby, J. Cardier, M. J. Murphy, S. D. Lyman, S. Lok, and S. E. W. Jakobson. 1996. Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3. Blood 88:4481.
56. Kobayashi, M., J. H. Laver, T. Kato, H. Miyazaki, and M. Ogawa. 1996. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 88:429.
57. Papayannopoulou, T., M. Brice, D. Farrer, and K. Kaushansky. 1996. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy. Exp. Hematol. 24:660.
58. - primitive progenitor cells. Blood 88:1619.
59. Zucker-Franklin, D., and K. Kaushansky. 1996. Effect of thrombopoietin on the development of megakaryocytes and platelets: an ultrastructural analysis. Blood 88:1632.